Wave Life Sciences Ltd. (TRADEGATE:1U5) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Kala Bio, Inc. (Director · Oct 3, 2018 – Mar 13, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Since at least Aug 14, 2015 |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Aug 16, 2021 |
| Mark Corrigan Other companies: Trevena, Inc. (Director · Jul 18, 2023 – Jun 13, 2024 · Past); Novelion Therapeutics Inc (Director · Mar 30, 2017 – Aug 9, 2018 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); CoLucid Pharmaceuticals Inc (Director · Oct 27, 2015 – Mar 1, 2017 · Past); Avanir Pharmaceuticals Inc (Director · Mar 18, 2014 – Mar 18, 2014 · Past); EPIRUS Biopharmaceuticals Inc (Director · Dec 21, 2009 – Jun 5, 2015 · Past); Cubist Pharmaceuticals Inc (Director · Jun 20, 2008 – Jan 21, 2015 · Past); Sepracor Inc (Executive VP, R&D · Mar 16, 2006 – Oct 20, 2009 · Past) | Director · Since at least Sep 4, 2019 |
| Christian Henry Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Since at least Sep 16, 2021); Pacific Biosciences of California, Inc. (Director · Since at least Jul 27, 2018); CM Life Sciences III Inc. (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Illumina, Inc. (EVP & Chief Commercial Officer · Jun 14, 2013 – Jan 30, 2017 · Past) | President and Chief Executive Officer, Pacific Biosciences · Since at least Nov 10, 2016 |
| Adrian Rawcliffe Other companies: Adaptimmune Therapeutics PLC (Chief Executive Officer, Director · Jan 1, 2016 – Feb 20, 2025 · Past); Human Genome Sciences Inc (Chief Financial Officer, Director · Jul 30, 2012 – Jul 30, 2012 · Past) | CEO-Partner and Chief Executive Officer · Since at least Feb 1, 2017 |
| Christopher Wright Other companies: Alkermes plc (Director · Since at least May 24, 2022); Cyclerion Therapeutics, Inc. (Chief Medical Officer · Feb 25, 2021 – Feb 25, 2021 · Past) | Chief Medical Officer · Since at least May 28, 2025 |
| Michael A. Panzara Other companies: Immunic, Inc. (Chief Medical Officer · Since at least Apr 24, 2026); LeonaBio, Inc. (Director · Since at least Mar 18, 2022) | See Remarks · Feb 1, 2021 – Jul 25, 2022 · Past |
| Amy Pott Other companies: enGene Therapeutics Inc. (Chief Global Comm. Ofc. · Since at least May 27, 2025) | Director · Sep 4, 2019 – Aug 18, 2020 · Past |
| Heidi L. Wagner Other companies: Alexion Pharmaceuticals Inc (SVP, Global Government Affairs · Oct 1, 2015 – Feb 27, 2018 · Past) | Director · Since at least Sep 4, 2019 |
| Keith Regnante Other companies: Keros Therapeutics, Inc. (CHIEF FINANCIAL OFFICER · Since at least Apr 7, 2020) | Chief Financial Officer · Aug 16, 2016 – Mar 7, 2019 · Past |
| Ken Takanashi Other companies: Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past) | Director · Since at least Aug 14, 2015 |
| Mark Baldry Other companies: X4 Pharmaceuticals, Inc. (Chief Commercial Officer · Nov 3, 2022 – May 16, 2025 · Past) | Chief Commerical Officer · Aug 5, 2019 – Aug 5, 2019 · Past |
| Paul B. Bolno Other companies: Invivyd, Inc. (Director · Since at least Sep 22, 2025) | President and Chief Executive Officer · Since at least Nov 10, 2015 |
| Roberto Guerciolini Other companies: Sirna Therapeutics Inc (Senior VP Development & CMO · Feb 21, 2006 – Dec 29, 2006 · Past) | See Remarks · Nov 10, 2015 – Dec 7, 2016 · Past |
| Aik Na Tan | Senior Vice President (Administration), Nanyang Technological University, Singapore · Since at least Aug 18, 2020 |
| Chandra Vargeese | See Remarks · Since at least Nov 10, 2015 |
| Chris Francis | See Remarks · Since at least Nov 10, 2015 |
| Daryn Lewis | Senior Vice President, Head of Human Resources · Since at least Nov 4, 2026 |
| Erik Ingelsson | Chief Scientific Officer · Since at least Apr 9, 2026 |
| Ginnie Yang | Senior Vice President, Translational Medicine · Since at least Nov 4, 2025 |
| Gregory L Verdine | Director · Since at least Jun 16, 2016 |
| James Salierno | Director, Investor Relations · Since at least Oct 27, 2026 |
| Kate Rausch | VP, Corporate Affairs and Investor Relations · Since at least Oct 27, 2026 |
| Ken Takanashi | Vice Chairman · Since at least Oct 7, 2026 |
| Koji Miura | Director · Nov 10, 2015 – Aug 15, 2019 · Past |
| Kyle Moran | Chief Financial Officer · Since at least Nov 10, 2015 |
| Linda Rockett | Senior Vice President, General Counsel · Since at least Nov 4, 2026 |
| Masaharu Tanaka | Director · Aug 14, 2015 – Sep 15, 2017 · Past |
| Monika Vnuk | Chief Business Officer · Since at least Sep 22, 2026 |
| Sridhar Vaddeboina | Senior Vice President, Chemistry, Manufacturing, and Controls · Since at least Nov 4, 2026 |